A high-performance liquid chromatography method with photodiode-array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs

Therapeutic Drug Monitoring

Volumn 25, Issue 5, 2003, Pages 565-573

  Duverneuil, Charlotte ^a   De la Grandmaison, Geoffroy Lorin ^a   De Mazancourt, Philippe ^a   Alvarez, Jean Claude ^a  

^a RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

HPLC; Nontricyclic antidepressants; Photodiode array

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NORFLUOXETINE; PAROXETINE; SERTRALINE; TOLOXATONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; VILOXAZINE;

ARTICLE; BLOOD SAMPLING; CHOLINERGIC TRANSMISSION; DEPRESSION; DRUG MONITORING; DRUG POTENCY; DRUG SCREENING; ELECTRON CAPTURE DETECTION; FLOW RATE; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIQUID LIQUID EXTRACTION; PHASE SEPARATION; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

ANTIDEPRESSIVE AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0141923074     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200310000-00005     Document Type: Article

References (21)

1. Kent JM. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet. 2000;355:911-918.
2. Goeringer KE, Raymon L, Christian GD, et al. Postmortem forensic toxicology of selective serotonin reuptake inhibitors: a review of pharmacology and report of 168 cases. J Forensic Sci. 2000;45:633-648.
3. Alvarez JC, Gluck N, Fallet A, et al. Plasma serotonin level after 1 day of fluoxetine treatment: a biological predictor for antidepressant response? Psychopharmacology. 1999;143:97-101.
4. Alvarez JC, Gluck N, Arnulf I, et al. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in unipolar depressed patients. Effects of clomipramine and fluoxetine. Clin Pharmacol Ther. 1999;66:617-624.
5. Tyrer SP, Marshall EF, Griffiths HW. The relationship between response to fluoxetine, plasma drug levels, imipramine binding to platelet membranes and whole-blood 5-HT. Prog Neuropsychopharmacol. 1990;14:797-805.
6. Patel J, Spencer EP, Flanagan RJ. HPLC of sertraline and norsertraline in plasma or serum. Biomed Chromatogr. 1996;10:351-354.
7. Brett MA, Dierdorf HD, Zussman BD. HPLC of sertraline and norsertraline in plasma or serum. J. Chromatogr. B. 1987;419:438-444.
8. Akerman KK, Jolkokonen J, Huttunen H, et al. High-performance liquid chromatography method for analyzing citalopram and desmethylcitalopram from human serum. Ther Drug Monit. 1998;20:25-29.
9. Meineke I, Schreeb K, Kres I, et al. Routine measurement of fluoxetine and norfluoxetine by high-performance liquid chromatography with ultraviolet detection in patients under concomitant treatment with tricyclic antidepressants. Ther Drug Monit. 1998;20:14-19.
10. Eap CB, Bouchoux G, Amey M, et al. Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry. J Chromatogr Sci. 1998;36:365-371.
11. Lacassie E, Gaulier JM, Marquet P, et al. Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography. J. Chromatogr. B. 2000;742:229-238.
12. Labat L, Deveaux M, Dallet P, et al. Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography. J. Chromatogr. B. 2002;773:17-23.
13. Rogowsky D, Marr M, Long G, et al. Determination of sertraline and desmethylsertraline in human serum using copolymeric bonded-phase extraction, liquid chromatography and gas chromatography-mass spectrometry. J Chromatogr B. 1994;655:138-141.
14. Fontanille P, Jourdil N, Villier C, et al. Direct analysis of fluoxetine and norfluoxetine in plasma by gas chromatography with nitrogen-phosphorus detection. J Chromatogr B. 1997;692:337-343.
15. Alvarez JC, Bothua D, Collignon I, et al. Determination of fluoxetine and its metabolite norfluoxetine in serum and brain areas using high-performance liquid chromatography with ultraviolet detection. J Chromatogr B. 1998;707:175-180.
16. Muth EA, Haskins JT, Moyer JA, et al. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol. 1986;35:4493-4497.
17. Sprouse J, Clarke T, Reynolds L, et al. Comparison of the effects of sertraline and its metabolite desmethylsertraline on blockade of central 5-HT reuptake in vivo. Neuropsychopharmacology. 1996;14:225-231.
18. Lacassie E, Ragot S, Gaulier JM, et al. A specific analytical method for the analysis of 24 antidepressants using gas chromatography-mass spectrometry (GC/MS). Acta Clinica Belg. [Suppl] 1999;1:20-24.
19. Geschke R, Komer J, Eggers H. Determination of the new monoamine oxidase inhibitor moclobemide and three of its metabolites in biological fluids by high-performance liquid chromatography. J Chromatogr. 1987;420:111-120.
20. Vistelle R, Lamiable D, Zinzou M. Simple high-performance liquid chromatographic method for the measurement of toloxatone in rabbit cerebrospinal fluid and plasma. J Chromatogr. 1989;490:387-394.
21. Vajta S, Le Moing JP, Rovei V. Gas-liquid chromatographic determination of toloxatone in human plasma. Routine analysis of a wide range of drug concentrations using a nitrogen-selective detector. J Chromatogr. 1983;274:139-148.